Cytokine release syndrome: grading, modeling, and new therapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1756-8722

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Cytokine release syndrome: grading, modeling, and new therapy ; volume:11 ; number:1 ; day:24 ; month:9 ; year:2018 ; pages:1-7 ; date:12.2018
Journal of hematology & oncology ; 11, Heft 1 (24.9.2018), 1-7, 12.2018

Creator: Liu, Delong

Contributor: Zhao, Juanjuan
SpringerLink (Online service)

DOI: 10.1186/s13045-018-0653-x

URN: urn:nbn:de:101:1-2018110721470752878801

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:55 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Liu, Delong
Zhao, Juanjuan
SpringerLink (Online service)

Other Objects (12)

Cytokine release syndrome

Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

Cytokine release syndrome after bronchoalveolar lavage

The Many Faces of Cytokine Release Syndrome-Related Coagulopathy

First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer

Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy

Cytokine release syndrome after radiation therapy: case report and review of the literature

Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience

Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy

Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome

Cytokine release syndrome

Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

Cytokine release syndrome after bronchoalveolar lavage

The Many Faces of Cytokine Release Syndrome-Related Coagulopathy

First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer

Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy

Cytokine release syndrome after radiation therapy: case report and review of the literature

Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience

Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy

Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome

Cytokine release syndrome

Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

Cytokine release syndrome after bronchoalveolar lavage

The Many Faces of Cytokine Release Syndrome-Related Coagulopathy

First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer

Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy

Cytokine release syndrome after radiation therapy: case report and review of the literature

Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience

Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy

Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Cytokine release syndrome: grading, modeling, and new therapy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Cytokine release syndrome

Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

Cytokine release syndrome after bronchoalveolar lavage

The Many Faces of Cytokine Release Syndrome-Related Coagulopathy

First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer

Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy

Cytokine release syndrome after radiation therapy: case report and review of the literature

Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience

Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy

Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome

Cytokine release syndrome

Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

Cytokine release syndrome after bronchoalveolar lavage

The Many Faces of Cytokine Release Syndrome-Related Coagulopathy

First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer

Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy

Cytokine release syndrome after radiation therapy: case report and review of the literature

Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience

Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy

Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome

Cytokine release syndrome

Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

Cytokine release syndrome after bronchoalveolar lavage

The Many Faces of Cytokine Release Syndrome-Related Coagulopathy

First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer

Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy

Cytokine release syndrome after radiation therapy: case report and review of the literature

Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience

Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy

Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome

Related objects

Reset password